FREE Case Review (866) 588-0600

Janssen Looks to Push Invokana Lawsuits out of Philadelphia

As the number of lawsuits filed in Philadelphia over Invokana continues to grow, Janssen Pharmaceuticals has begun looking to send the complaints elsewhere.

As the number of lawsuits filed in Philadelphia over the type 2 diabetes medication Invokana (generic: canagliflozin) continues to grow, Janssen Pharmaceuticals has begun looking to send the complaints elsewhere.

Free Confidential Lawsuit Evaluation: If you or a loved one was injured by Invokana side effects, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against Janssen and our lawyers can help.

What’s the Problem?

May 16, 2016 – The drugmaker filed a forum non ­conveniens motion last week seeking to have the case Jeffries v. Janssen Pharmaceuticals transferred from the Philadelphia Court of Common Pleas to Tennessee, the plaintiff’s home state. This is the first such motion to be filed over Invokana in Philly, but Janssen is reviewing “all other cases filed in Philadelphia and will file such motions when similar ­out-of-state facts exist,” according to company spokeswoman Kaitlin Meiser.

“Plaintiff’s decision to file suit in Philadelphia County is part of a trend where plaintiffs who have no connection to Pennsylvania demand that the ­taxpayers and courts of Philadelphia County hear their claims,” Meiser said. “In this case, we are asking the court to dismiss the claims of the plaintiff who never lived in Pennsylvania and does not claim her ­alleged injuries occurred in the state.”

This year has seen numerous Invokana lawsuits filed in the Philadelphia Court of Common Pleas. Last month alone at least 15 such cases were filed, and court records indicate at least 33 pending cases on the books there.

Although the plaintiffs have not yet sought to consolidate the lawsuits into a mass tort, a request has been made to informally coordinate case management and other status ­conferences for complaints related to Invokana.

The litigation has thus far centered on allegations that Invokana causes kidney failure and diabetic ketoacidosis (DKA), a condition that occurs when the body produces high levels of blood acids called ketones. Jeffries claims in her lawsuits that she developed both conditions as well as a stroke as the result of using Invokana.

The forum non conveniens motion argues that Jeffries’ complaint should be moved to Tennessee because she allegedly used the drug, was injured and underwent medical care in that state. Additionally, the motion contends that the lawsuit has no connection with Pennsylvania, as none of the research and development, marketing or decision making that led to the development of Invokana are based in Pennsylvania.

Do I Have an Invokana Lawsuit?

The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Invokana lawsuits. We are handling individual litigation nationwide and currently accepting investigating potential settlements in all 50 states.

Free Confidential Case Evaluation: Again, if you were injured by Invokana, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
*
*
*

Awards & recognition